Skip to content

Clinical Toxicology

ISSN 1556-9519, 0009-9309

55 papers in the library · 1,118 citations · publishing 1975-2026

Papers

Sort Most recent Most cited

Bad trip due to 25I-NBOMe: a case report from the EU project SPICE II plus.

Clinical Toxicology September 1, 2017 Maren Hermanns‐clausen, Verena Angerer, Josephine Kithinji et al. 22 citations

The potent hallucinogenic drug 25I-NBOMe has recently emerged on the drug market. We present a case with analytically confirmed 25I-NBOMe intoxication from the prospective study "SPICE II Plus". Because of a severe headache a 42-year-old man took one sip of a pediatric analgesic syrup, which had been refilled with a self-made solution of 25I-NBOMe in ethanol. Thirty minutes later restlessness...

DOI: 10.1080/15563650.2017.1319572 (opens in new tab) Full text (opens in new tab) 25i-nboh 25i-nbome 2c-i New psychoactive substances +17

Toxicokinetics of ibogaine and noribogaine in a patient with prolonged multiple cardiac arrhythmias after ingestion of internet purchased ibogaine.

Clinical Toxicology July 1, 2017 Marieke Henstra, Liza Wong, Abdel Chahbouni et al. 13 citations

Ibogaine is an agent that has been evaluated as an unapproved anti-addictive agent for the management of drug dependence. Sudden cardiac death has been described to occur secondary to its use. We describe the clinical effects and toxicokinetics of ibogaine and noribogaine in a single patient. For this purpose, we developed a LC-MS/MS-method to measure ibogaine and noribogaine...

DOI: 10.1080/15563650.2017.1287372 (opens in new tab) Full text (opens in new tab) Lc-ms/ms method Cardiac arrhythmia Ibogaine toxicokinetics ibogaine Cardiac effects +12

No clinically relevant effects in children after accidental ingestion of Panaeolina foenisecii (lawn mower's mushroom).

Clinical Toxicology March 2017 Katharina M Schenk-Jaeger, Katharina E Hofer-Lentner, Bettina Plenert et al.

Panaeolina foenisecii is one of the most common and widely distributed lawn mushrooms in Europe and North America, and frequently involved in accidental mushroom ingestion, mainly in children. Nevertheless, there is contradictory information regarding the toxicity profile of P. foenisecii in the literature. Objective of the study was to assess clinical effects with particular attention on...

Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the Identification Of Novel psychoActive substances (IONA) study.

Clinical Toxicology September 1, 2016 Simon L Hill, Javad Najafi, Michael Dunn et al.

Recreational use of Synthetic Cannabinoid Receptors Agonists (SCRAs) has become increasingly common in many countries and may cause severe toxic effects. To describe the clinical features of toxicity in seven men after analytically confirmed exposure to MDMB-CHMICA, a recently described indole-based SCRA. Clinical information and biological samples (blood, urine) were collected from patients...

How toxic is ibogaine?

Clinical Toxicology 2016 Ruud P. W. Litjens, Tibor M Brunt 74 citations

Ibogaine is a psychoactive indole alkaloid found in the African rainforest shrub Tabernanthe Iboga. It is unlicensed but used in the treatment of drug and alcohol addiction. However, reports of ibogaine's toxicity are cause for concern. To review ibogaine's pharmacokinetics and pharmacodynamics, mechanisms of action and reported toxicity. A search of the literature available on PubMed was done,...

Case series: toxicity from 25B-NBOMe--a cluster of N-bomb cases.

Clinical Toxicology 2016 Paul Gee, Leo J. Schep, Berit P Jensen et al.

Background A new class of hallucinogens called NBOMes has emerged. This class includes analogues 25I-NBOMe, 25C-NBOMe and 25B-NBOMe. Case reports and judicial seizures indicate that 25I-NBOMe and 25C-NBOMe are more prevalently abused. There have been a few confirmed reports of 25B-NBOMe use or toxicity. Report Observational case series. This report describes a series of 10 patients who suffered...

DOI: 10.3109/15563650.2015.1115056 (opens in new tab) Full text (opens in new tab) 25b-nbome N-bomb Novel psychoactive substances Substituted phenylethylamines

Phencyclidine analog use in Sweden--intoxication cases involving 3-MeO-PCP and 4-MeO-PCP from the STRIDA project.

Clinical Toxicology November 1, 2015 Matilda Bäckberg, Olof Beck, Anders Helander

3-Methoxy-phencyclidine (3-MeO-PCP) and 4-methoxy-phencyclidine (4-MeO-PCP) are analogs of and drug substitutes for the dissociative substance PCP ("Angel dust"), a recreational drug that was most popular in the 1970s. In Sweden, use of methoxylated PCP analogs was noted starting in mid-2013, according to statistics from the Poisons Information Centre. The objective of this case series was to...

DOI: 10.3109/15563650.2015.1079325 (opens in new tab) Full text (opens in new tab) 3-meo-pcp 4-meo-pcp Arylcyclohexylamines Designer drugs +10

Intoxications by the dissociative new psychoactive substances diphenidine and methoxphenidine

Clinical Toxicology May 8, 2015 Anders Helander, O. Beck, Matilda Bäckberg

BACKGROUND: Diphenidine (1-(1,2-diphenylethyl)piperidine) and its 2-methoxylated derivative methoxphenidine (MXP, 2-MeO-diphenidine) are substances with dissociative effects that were recently introduced for "recreational" purpose through the online-based sale of new psychoactive substances (NPS). A number of analytically confirmed non-fatal intoxications associated with diphenidine or MXP have...

Acute behavioural disturbance associated with phenibut purchased via an internet supplier.

Clinical Toxicology 2015 Michael A Downes, Ingrid L Berling, Ahmed Mostafa et al.

Toxicity from recreational substances marketed for other purposes is a well-documented clinical entity. We present two cases of phenibut toxicity procured via the internet. A 20-year-old female presented to the emergency department (ED) having used phenibut the prior day. The main finding was a decreased level of consciousness, however when roused she became delirious. Supportive care only was...

Acute toxicity associated with the recreational use of the novel dissociative psychoactive substance methoxphenidine.

Clinical Toxicology December 1, 2014 Katharina E Hofer, Colette Degrandi, Daniel Müller et al.

Methoxphenidine is a novel dissociative designer drug of the diarylethylamine class which shares structural features with phencyclidine (PCP), and is not at present subject to restrictive regulations. There is very limited information about the acute toxicity profile of methoxphenidine and the only sources are anonymous internet sites and a 1989 patent of the Searle Company. We report a case of...

Patterns of presentation and clinical toxicity after reported use of alpha methyltryptamine in the United Kingdom. A report from the UK National Poisons Information Service

Clinical Toxicology February 28, 2014 Ashraf Kamour, David A. James, Robert Spears et al. 23 citations

OBJECTIVE: To characterise the patterns of presentation, clinical effects and possible harms of acute toxicity following recreational use of alpha methyltryptamine (AMT) in the United Kingdom, as reported by health professionals to the National Poisons Information Service (NPIS) and to compare clinical effects with those reported after mephedrone use. METHODS: NPIS telephone enquiries and...

DOI: 10.3109/15563650.2014.885983 (opens in new tab) Presentation obstetrics Toxicity Alpha finance Medical emergency +1

Three months of methoxetamine administration is associated with significant bladder and renal toxicity in mice

Clinical Toxicology February 28, 2014 Paul I Dargan, H. Tang, W. Liang et al.

UNLABELLED: CONTEXT.: Methoxetamine is a ketamine analogue that has recently emerged as a novel psychoactive substance. Chronic ketamine use is associated with significant bladder and renal toxicity. Methoxetamine has been marketed as "bladder friendly", but there is no data to be able to substantiate this claim. OBJECTIVE: To characterise the patterns of bladder and renal toxicity associated...

Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe

Clinical Toxicology 2014 Magdalene H Y Tang, CK Ching, M. S. H. Tsui et al. 93 citations

CONTEXT: A new group of novel psychoactive substance, the N-methoxybenzyl (NBOMe) derivatives of substituted phenethylamine, has recently emerged on the drug market, among which 25I-NBOMe and 25B-NBOMe have previously been implicated in clinical intoxications and fatalities. We report two cases of acute intoxication associated with these substances. CASE DETAILS: Two male patients (17 and 31...

A case of 25I-NBOMe (25-I) intoxication: a new potent 5-HT2A agonist designer drug

Clinical Toxicology March 1, 2013 S. Rose, Justin L. Poklis, Alphonse Poklis

Context. Abuse of synthetic stimulant compounds resulting in significant toxicity is being increasingly reported by poison centers. Toxicologic assessment is complicated by inconsistent manufacturing processes and limited laboratory testing. We describe a case of self-reported exposure to 25-I (25I-NBOMe), a novel phenethylamine derivative, with subsequent quantification in serum. Case details....

Pre-treatment of BALB/c mice with a centrally acting serotonin antagonist (cyproheptadine) reduces mortality from Boophone disticha poisoning.

Clinical Toxicology 2013 M Mutseura, D Tagwireyi, L L Gadaga 7 citations

Crude extracts of Boophone disticha are used in Southern African traditional medical practice for the management of various illnesses and conditions and have also been abused for their claimed euphoric and hallucinogenic effects. Unfortunately, ingestion of Boophone disticha has resulted in toxicity and death. The results of a recent acute toxicity study in a rat model insinuated that central...

Methoxetamine associated reversible cerebellar toxicity: Three cases with analytical confirmation

Clinical Toxicology May 11, 2012 Jennifer Shields, Paul I Dargan, David M Wood et al.

CONTEXT: There have been recent concerns about increasing use and accessibility of methoxetamine, a ketamine derivative. Few data are available to describe the clinical features associated with methoxetamine exposure. We report three cases that presented to hospital with acute neurological toxicity associated with analytically confirmed methoxetamine exposure. CASE DETAILS: A 19-year-old male...

Clinical toxicology of newer recreational drugs

Clinical Toxicology October 1, 2011 S. Hill, Simon H. L. Thomas 289 citations

There are limited reliable data to guide clinicians managing patients with toxicity due to these substances. The harms associated with emerging recreational drugs are not fully documented, although it is clear that they are not without risk. Management of users with acute toxic effects is pragmatic and primarily extrapolated from experience with longer established stimulant or hallucinogenic...

DOI: 10.3109/15563650.2011.615318 (opens in new tab) Clinical toxicology Recreational drug Pharmacology Intensive care medicine

γ-Hydroxybutyrate: experience of 9 years of γ-hydroxybutyrate (GHB)-related incidents during rave parties in The Netherlands.

Clinical Toxicology April 1, 2011 Jan Krul, Armand R J Girbes

OBJECTIVE. The objective of this study was to determine the health disturbances and to assess the severity of the incidents as reported during a 9-year experience of gamma-hydroxybutyrate (GHB)-related First Aid Attendees attending First Aid Stations at rave parties. DESIGN. This study was a prospective observational study of self-referred patients from the year 2000 to 2008. During rave...

Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation.

Clinical Toxicology August 2010 Donna Seger

This article reviews the role and clinical importance of specific neuroadaptations that may occur following use of cocaine, metamfetamine, and 3,4,methylenedioxymetamfetamine (MDMA). A literature search was performed using OVID MEDLINE and PubMed for all years to the present date, which identified 250 papers of which 154 were considered relevant. MECHANISMS OF ACTION OF COCAINE AND...

Peyote and mescaline exposures: a 12-year review of a statewide poison center database

Clinical Toxicology 2010 Shaun D. Carstairs, F. Lee Cantrell 48 citations

Although uncommonly encountered, use of peyote and mescaline was associated with clinically significant effects requiring treatment in a substantial number of patients. Clinical effects were usually mild or moderate, and life-threatening toxicity was not reported in this case series.

DOI: 10.3109/15563650903586745 (opens in new tab) Mescaline Mydriasis Poison control center Vomiting +2

Bioanalytical and clinical evaluation of 103 suspected cases of intoxications with psychoactive plant materials.

Clinical Toxicology July 1, 2009 Kristian Björnstad, Peter Hultén, Olof Beck et al. 35 citations

Problems associated with the increasing abuse of plant-derived psychoactive substances have recently attracted attention. This study involved bioanalytical and clinical examinations of intoxication cases suspected to be linked to such plant materials. Urine samples were collected at emergency wards in Sweden from patients who either admitted or were suspected of ingestion of psychoactive plant...